Effect of cognitive behavior therapy on HbA1c and psychological factor on patient with diabetic type 2

The effect of Cognitive behavior group training on HbA1C self efficacy, depression, illness perception and quality of life in patient with diabetes type II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017021832637N1

Enrollment

Registered

2017-05-12

Start date

2012-04-29

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2 - Depression. Non-insulin-dependent diabetes mellitus,Depressive episode

Interventions

Intervention 1: Type of intervention: Cognitive- Behavioral group training ,5 weeks ,10 sessions, two days a week ,duration 1.5 hours/ Sessions. Intervention 2: The control group does not receive any

Type of intervention: Cognitive- Behavioral group training ,5 weeks ,10 sessions, two days a week ,duration 1.5 hours/ Sessions

The control group does not receive any treatment

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients have diabetes type II; at least a diploma ; resident of Sari city; HbA1C between 6.5 – 8 % FBS = 126 mg/dl , 2hrpp = 180 mg / dl ; patients have depression disorder ?Exclusion criteria: Patients who received antidepressants.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: pretest-posttest control group. Method of measurement: in medical lab with Nicocard kit.;Depression. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: Beck depression Inventory.;Self- efficacy. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: DMSES questionnaire.;Quality Of life. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: D39 questionnaire.;Illness Perception. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: IPQ questionnaire.	—

Measure

Time frame

HbA1c. Timepoint: pretest-posttest control group. Method of measurement: in medical lab with Nicocard kit.;Depression. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: Beck depression Inventory.;Self- efficacy. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: DMSES questionnaire.;Quality Of life. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: D39 questionnaire.;Illness Perception. Timepoint: pretest-posttest control group and one month follow-up. Method of measurement: IPQ questionnaire.

—

Secondary

Measure	Time frame
Without secondary measure. Timepoint: none. Method of measurement: none.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohammad ali barzegar damadi

with me corresponding writter

mbarzegar2020@gmail.com+98 11 4204 4744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026